Home medical beauty device that responds to heartbeats (patent pending)

The global home-use beauty device industry is experiencing explosive growth, driven by consumer demand for clinical-grade dermatological treatments at home. However, first-generation devices face structural efficacy ceilings due to fixed-frequency, unilateral energy output. Tink Innovation introduces an essential paradigm shift: Bio-Signal Synchronized Electro-Optical Hybrid Stimulation.

By embedding dual Photoplethysmography (PPG) sensing and real-time hemodynamic phase-tracking algorithms into a handheld form factor, this patented architecture captures the user's microvascular cardiac cycle (Systole vs. Diastole) and delivers targeted electrical-optical energy strictly during the physiological "Optimal Permeability Window."

Tink Innovation, the company making this proposal, has completed the filing of this source patent in Korea and is preparing for a PCT international application for overseas expansion. Through this proposal, we officially propose a patent technology transfer (sale of rights/licensing) or a joint venture (JV) product commercialization business targeting beauty device manufacturers, global cosmeceutical companies, and healthcare investment institutions.